Atlas Trials

Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes

Clinical trial NCT05819138 · RECRUITING

Trial details

NCT number
NCT05819138
Sponsor
University of Colorado, Denver
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 1
Start date
2023-06-21
Primary completion
2027-10-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.